CINXE.COM

Clinical Trials Register

<!DOCTYPE html> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=8" /> <meta name="description" content=""> <link type="text/css" href="/ctr-search/css/960.css" rel="stylesheet"/> <link type="text/css" href="/ctr-search/css/reset.css" rel="stylesheet"/> <link type="text/css" href="/ctr-search/css/text.css" rel="stylesheet"/> <link type="text/css" href="/ctr-search/css/print.css" rel="stylesheet" media="print"/> <link type="text/css" href="/ctr-search/css/jquery-ui.css" rel="stylesheet" /> <link type="text/css" href="/ctr-search/css/styles.css" rel="stylesheet"/> <link type="text/css" href="/ctr-search/css/nav.css" rel="stylesheet"/> <script type="text/javascript">var ctx = "/ctr-search"</script> <script type="text/javascript" src="/ctr-search/js/jquery.js"></script> <script type="text/javascript" src="/ctr-search/js/jquery.ui.datepicker.js"></script> <script type="text/javascript" src="/ctr-search/js/jquery.ui.core.js"></script> <script type="text/javascript" src="/ctr-search/js/jquery.ui.widget.js"></script> <script type="text/javascript" src="/ctr-search/js/jquery.ui.tabs.js"></script> <script type="text/javascript" src="/ctr-search/js/wtooltip.js"></script> <script type="text/javascript" src="/ctr-search/js/init.js"></script> <script type="text/javascript">$(searchInit);</script> <title> Clinical Trials Register </title> </head> <body> <div id="headerContainer" class="width100"> <table id="logoContainer" class="container_12"> <tbody> <tr> <td width="55"> <img alt="Flag of the European Union" height="53" src="/ctr-search/img/euFlag.png" > <td> <td width="586" > <span class="bannerText" >EU Clinical Trials Register</span> </td> <td width="307" > <span class="headernav"><a href="/help.html">Help</a></span> </td> </tr> </tbody> </table> <table id="mainMenuContainer" class="container_12"> <tbody> <tr> <td> <ul id="nav" class="mainMenu width100 margin0"> <li class="selected underL"> <a title="EU Clinical Trials Register home page" href="/ctr-search/search">Home & Search</a> </li> <li class="underL"> <a title="Click to view Joining a Clinical Trial page" href="/joiningtrial.html">Joining a trial</a> </li> <li class="underL"> <a title="Click to view the EU Clinical Trials Register Contacts page" href="/contacts.html">Contacts</a> </li> <li class="underL"> <a title="About" href="/about.html">About</a> <ul style="width: 250px;"> <li><a href="/about.html">About the EU clinical trials register</a></li> <li><a href="/whatsNew.html">What's new</a></li> <li><a href="/dataquality.html">Data quality</a></li> <li><a href="/doc/Sponsor_Contact_Information_EUCTR.pdf">Clinical trial sponsors</a></li> <li><a href="/natauthorities.html">National medicine regulatory authorities</a></li> <li><a href="/links.html">Links</a></li> </ul> </li> <li class="underL"> <a title="Click to view the EU Clinical Trials Register News update" href="/index.html">News update</a> </li> </ul> </td> </tr> </tbody> </table> </div> <div class="container_12"> <div class="grid_12 marginB12"> <h1> Clinical trials </h1> <span> The <a href="/about.html">European Union Clinical Trials Register</a> &nbsp; allows you to search for protocol and results information on: <li> interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC </li> <li> clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development </li> </span> <br/> <span> EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the <br/> <a href="https://euclinicaltrials.eu/">Clinical Trials Information System (CTIS). </a> </span> <br/><br/> <span> The EU Clinical Trials Register currently displays &nbsp; <strong><span id="total">44229</span></strong> &nbsp; clinical trials with a EudraCT protocol, of which &nbsp; <strong><span id="under18">7336</span></strong> &nbsp; are clinical trials conducted with subjects less than 18 years old. &nbsp; The register also displays information on &nbsp; <strong><span id="article45Count">18700</span></strong> &nbsp; older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006). </span> <br/><br/> <span> Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see <a href="https://eudract.ema.europa.eu/docs/guidance/EudraCT%20FAQ_for%20publication.pdf" target="_blank">Frequently Asked Questions ).</a> &nbsp; </span> </div> </div> <div class="container_12"> <div class="grid_2">&nbsp;</div> <div id="searchContainer" class="grid_8"> <script type="text/javascript" src="/ctr-search/js/jsoup.js"></script> <form id="search-form" action="/ctr-search/search" method="get"> <input id="query" class="padding04 alpha omega" name="query" value="" accesskey="s" tabindex="1" autofocus placeholder="Please enter search term..." style="float: left; width: 437px;"/> <input id="reset" type="button" value="X" class="resetButton" accesskey="r" title="Delete search term"/> <span class="submit-button"><input type="submit" id="submitbutton" value="Search" class="grid_2 omega" accesskey="x" tabindex="2"/></span> <div class="hints"> <div style="padding-left: 10px;"> <strong>Examples:</strong> Cancer AND drug name. Pneumonia AND sponsor name. <br/> <a href="/doc/How_to_Search_EU_CTR.pdf#zoom=100,0,0" target="_blank"> How to search [pdf] </a> </div> <div style="display:none"> <strong>Search Tips:</strong> Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field. </div> </div> <table id="advancedSearch" class="width40"> <tr> <td><strong>Advanced Search:</strong></td> <td><a id="advanced-link" class="" href="javascript:void(0)" accesskey="a" tabindex="3">Search tools</a></td> </tr> </table> <script type="text/javascript"> $('#submitbutton').click(function(event) { $('#search-form').submit(); }); $("#advancedSearch").click(function() { $('#advanced-link').toggleClass('clicked'); return false; }); </script> <div id="advanced-controls" style="margin: 1em 0em;display:none"> <table id="advancedAll" class="width100 advancedOptions"> <tr> <td>Select Country:<br/> <select class="search-field advanced" name="country" multiple="multiple" size="4" accesskey="c" tabindex="4"> <option value="at" >Austria</option> <option value="be" >Belgium</option> <option value="bg" >Bulgaria</option> <option value="hr" >Croatia</option> <option value="cy" >Cyprus</option> <option value="cz" >Czechia</option> <option value="dk" >Denmark</option> <option value="ee" >Estonia</option> <option value="fi" >Finland</option> <option value="fr" >France</option> <option value="de" >Germany</option> <option value="gr" >Greece</option> <option value="hu" >Hungary</option> <option value="is" >Iceland</option> <option value="ie" >Ireland</option> <option value="it" >Italy</option> <option value="lv" >Latvia</option> <option value="li" >Liechtenstein</option> <option value="lt" >Lithuania</option> <option value="lu" >Luxembourg</option> <option value="mt" >Malta</option> <option value="nl" >Netherlands</option> <option value="no" >Norway</option> <option value="pl" >Poland</option> <option value="pt" >Portugal</option> <option value="ro" >Romania</option> <option value="sk" >Slovakia</option> <option value="si" >Slovenia</option> <option value="es" >Spain</option> <option value="se" >Sweden</option> <option value="gb" >United Kingdom</option> <option value="3rd" >Outside EU/EEA</option> </select> </td> <td>Select Age Range:<br/> <select class="search-field advanced" name="age" multiple="multiple" size="4" accesskey="g" tabindex="5"> <option value="adolescent" >Adolescent</option> <option value="adult" >Adult</option> <option value="children" >Children</option> <option value="elderly" >Elderly</option> <option value="in-utero" >In-Utero</option> <option value="infant-and-toddler" >Infant and Toddler</option> <option value="newborn" >Newborn</option> <option value="preterm-new-born-infants" >Preterm new born infants</option> <option value="under-18" >Under 18</option> </select> </td> </tr> <tr> <td>Select Trial Status:<br/> <select class="search-field advanced" name="status" multiple="multiple" size="4" accesskey="u" tabindex="6"> <option value="completed" >Completed</option> <option value="not-authorised" >Not Authorised</option> <option value="ongoing" >Ongoing</option> <option value="prematurely-ended" >Prematurely Ended</option> <option value="prohibited-by-ca" >Prohibited by CA</option> <option value="restarted" >Restarted</option> <option value="suspended-by-ca" >Suspended by CA</option> <option value="temporarily-halted" >Temporarily Halted</option> <option value="trial-now-transitioned" >Trial Now Transitioned</option> </select> </td> <td>Select Trial Phase:<br/> <select class="search-field advanced" name="phase" multiple="multiple" size="4" accesskey="f" tabindex="7"> <option value="phase-one" >Phase One</option> <option value="phase-two" >Phase Two</option> <option value="phase-three" >Phase Three</option> <option value="phase-four" >Phase Four</option> </select> </td> </tr> <tr> <td colspan="2"> Select Gender:<br/> <select class="search-field advancedSmall advanced" name="gender" size="1" accesskey="t" tabindex="8"> <option value="" ></option> <option value="both" >Both</option> <option value="female-only" >Female Only</option> <option value="male-only" >Male Only</option> </select> </td> </tr> <tr> <td colspan="2">Select Date Range:<br/> <input style="margin-left: 20px" class="search-field advanced calendar" type="text" name="dateFrom" value="" accesskey="r" tabindex="9"> to <input class="search-field advanced calendar" type="text" name="dateTo" value="" ky="t" tabindex="10"> </td> </tr> <tr> <td colspan="2">Select Rare Disease: <input class="search-field advanced" type="checkbox" name="rare" value="true" tabindex="11" > </td> </tr> <tr> <td colspan="2" style="white-space: nowrap;padding-right:2em">IMP with orphan designation in the indication <input class="search-field advanced" type="checkbox" name="orphanimp" value="true" tabindex="12" > </td> </tr> <tr> <td colspan="2">Orphan Designation Number:<br/> <input style="margin-left: 20px" class="search-field advanced orphantext" type="text" name="orphannum" value=""> </td> </tr> <tr> <td colspan="2">Results Status:<br/> <select class="search-field advancedSmall advanced" name="resultsstatus" size="1" accesskey="t" tabindex="8"> <option value="" ></option> <option value="trials-with-results" >Trials with results</option> <option value="trials-without-results" >Trials without results</option> </select> </td> </tr> <tr> <td style="border-style:none;padding:20px 2px 0;"><a href="javascript:void(0)" id="advanced-clear">Clear advanced search filters</a></td> <td style="border-style:none;padding:20px 2px 0;" class="submit-button"><input type="submit" value="Search" class="grid_2" accesskey="x" tabindex="13"/></td> </tr> </table> </div> </form> </div> <div class="grid_2">&nbsp;</div> </div> <div id="content" class="container_12"> <script type="text/javascript"> document.title = 'Clinical Trials register'; </script> <div class="search" style="display:none"> <a id="download-link" href="javascript:void(0)" class="download" style="padding-right: 2em;"> Download Options </a> <a id="showFeed" href="javascript:void();" style="display:none"> Subscribe to this Search </a> </div> <div id="tabs" class="container_12"> <ul> <li> <a id="ui-id-1" href="#tabs-1"> Trials with a EudraCT protocol (44,229) </a> </li> <li> <a id="ui-id-2" href="#tabs-2"> Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700) </a> </li> </ul> <div id="tabs-1" style="display:inline-block" class="grid12"> <div class="outcome grid_12"> 44,229 result(s) found. Displaying page 1 of 2,212. </div> <div class="pager grid_8plus" class="margin-bottom: 6px;"> <strong>1</strong>&nbsp; <a href="&page=2">2</a>&nbsp; <a href="&page=3">3</a>&nbsp; <a href="&page=4">4</a>&nbsp; <a href="&page=5">5</a>&nbsp; <a href="&page=6">6</a>&nbsp; <a href="&page=7">7</a>&nbsp; <a href="&page=8">8</a>&nbsp; <a href="&page=9">9</a>&nbsp; <a href="&page=2" accesskey="n"> Next&#187; </a> <a href="&page=2212"> Last&#187;&#187; </a> </div> <div class="results grid_8plus"> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2008-006649-18" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2008-006649-18 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> 08/0214</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2011-11-16</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>University College London </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy with CMV TCR-transduced Donor-derived T cells for Recipients of Allogeneic Haematopoietic Stem Cell ...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> CMV reactivation/infection in post allogeneic haematopoietic stem cell transplant recipients. Allo-HSCT being performed for underlying haematological malignancy (eg, AML, ALL, NHL, Hodgkin Lymphoma...</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.0</td> <td>100000004865</td> <td>10067859</td> <td>Allogenic stem cell transplantation</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2008-006649-18/GB">GB</a> <span class="status">(Prematurely Ended)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2008-006649-18/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2008-004874-42" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2008-004874-42 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> TRAFO001</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2009-02-06</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Institut f眉r Frauengesundheit GmbH </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Evaluation of predictive Factors for the Effectivity of Aromatase Inhibitor Therapy - Offene, prospektive, multizentrische Phase IV-Studie zur Untersuchung des Einflusses von pharmakogenetischen M...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> The study examines the influence of pharmacogenetic markers on the efficacy and side effects in postmenopausal, steroid hormone positive breast cancer patients, who are treated with Letrozol. The p...</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>20.0</td> <td>10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)</td> <td>10006187</td> <td>Breast cancer</td> <td>PT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2008-004874-42/DE">DE</a> <span class="status">(Ongoing)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2008-002768-32" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2008-002768-32 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> MM03</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2009-06-08</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Freistaat Bayern </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A prospective phase I/II, one-arm, one-stage multi-center, open label study of lenalidomide in combination with pioglitazone, dexamethasone and metronomic low-dose chemotherapy with treosulfan in p...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Multiple myeloma</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>21.0</td> <td>100000004864</td> <td>10028228</td> <td>Multiple myeloma</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2008-002768-32/DE">DE</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2010-022400-53" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2010-022400-53 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> NLH-01</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2011-01-13</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>K酶ge Hospital </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Intracoronary administration of melatonin for patients with acute myocardial infarction: a placebo controlled randomized study.</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Acute Myocardial Infarction</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>18.1</td> <td>10007541 - Cardiac disorders</td> <td>10000891</td> <td>Acute myocardial infarction</td> <td>PT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2010-022400-53/DK">DK</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2010-022400-53/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2008-003174-18" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2008-003174-18 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> PACET-CUP</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2009-12-18</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Universit盲tsklinikum Heidelberg </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Open-labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated ...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> adeno- and undifferentiated Carcinoma of Unknown Primary (CUP)</td> </tr> <tr> <td colspan="3"> <span class="label">Disease:</span> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2008-003174-18/DE">DE</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2006-001095-21" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2006-001095-21 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> A5I16</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2016-04-19</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Sanofi Pasteur Inc. </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Immunogenicity and Safety of PEDIACEL庐, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed),...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Pertussis, adsorbed diphtheria and tetanus toxoids, inactivated poliomyelitis and polysaccharide of H. influenza type b bound to tetanus toxoid</td> </tr> <tr> <td colspan="3"> <span class="label">Disease:</span> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Infants and toddlers, Under 18</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2006-001095-21/3rd">Outside EU/EEA</a> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2006-001095-21/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2006-000653-22" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2006-000653-22 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> GART1013</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2006-07-26</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Moorfields Eye Hospital </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> The UK Glaucoma Treatment Study</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Primary open-angle Glaucoma Pseudoexfoliation Glaucoma</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>20.0</td> <td>100000004853</td> <td>10037118</td> <td>Pseudoexfoliation glaucoma</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2006-000653-22/GB">GB</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2006-000653-22/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2008-000581-23" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2008-000581-23 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> CSPP100A2244</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2008-07-28</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Novartis Pharma AG </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A randomized, double-masked, placebo-controlled add on study to assess the efficacy of oral aliskiren 300 mg once daily for diabetic macular edema</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Diabetic Macular Edema (DME) in hypertensive patients</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.0</td> <td>100000004853</td> <td>10057915</td> <td>Diabetic macular oedema</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2008-000581-23/DK">DK</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2008-000581-23/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2007-001058-16" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2007-001058-16 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> V00147GL202</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2007-04-30</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>PIERRE FABRE MEDICAMENT </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 碌G) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Erectile dysfunction </td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>21.1</td> <td>10038604 - Reproductive system and breast disorders</td> <td>10052004</td> <td>Organic erectile dysfunction</td> <td>PT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults</td> <td><span class="label">Gender:</span> Male</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2007-001058-16/FR">FR</a> <span class="status">(Prematurely Ended)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2007-001058-16/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2008-007225-39" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2008-007225-39 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> CareRA</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2009-01-06</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>University Hospitals Leuven </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A 2 year prospective multicentre randomised controlled trial comparing effectiveness in daily practice of different treatment strategies for early RA</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> early active Rheumatoid Arthritis, previously untreated with DMARDS</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>20.0</td> <td>10028395 - Musculoskeletal and connective tissue disorders</td> <td>10039073</td> <td>Rheumatoid arthritis</td> <td>PT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2008-007225-39/BE">BE</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2008-007225-39/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2010-023062-40" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2010-023062-40 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> PRP-001</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2011-04-19</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Medivation, Inc. </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered Talazoparib (BMN 673) in Patients with Advanced or Recurrent Solid Tumors</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Advanced or recurrent solid tumors for which there is no accepted standard treatment or for which standard treatment has failed. Patients may also be eligible if they are unable or decline to unde...</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.0</td> <td>100000004864</td> <td>10065147</td> <td>Malignant solid tumor</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2010-023062-40/GB">GB</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2010-023062-40/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2009-016877-14" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2009-016877-14 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> H1N1-2009</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2009-11-04</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>COPSAC </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A-H1N1v Vaccination in Pregnant Women</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Protection against Influenza A H1N1v disease</td> </tr> <tr> <td colspan="3"> <span class="label">Disease:</span> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18, Adults</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2009-016877-14/DK">DK</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2011-002044-28" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2011-002044-28 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> HGT-MLD-070</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2012-06-14</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Shire Human Genetics Therapies Inc </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A Phase I/II, Multicenter, Open-label, Dose Escalation Study of HGT-1110 Administered Intrathecally in Children with Metachromatic Leukodystrophy</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Treatment of Metachromatic Leukodystrophy</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.0</td> <td>10010331 - Congenital, familial and genetic disorders</td> <td>10067609</td> <td>Metachromatic leukodystrophy</td> <td>PT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Infants and toddlers, Children, Under 18</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2011-002044-28/DE">DE</a> <span class="status">(Completed)</span> <a href="/ctr-search/trial/2011-002044-28/DK">DK</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2011-002044-28/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2013-001048-73" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2013-001048-73 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> BAY41-6551/13084</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2013-07-25</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Bayer AG </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Pati...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Gram-negative pneumonia</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.0</td> <td>100000004862</td> <td>10035701</td> <td>Pneumonia gram-negative bacterial NOS</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2013-001048-73/CZ">CZ</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2013-001048-73/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2012-001650-26" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2012-001650-26 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> AnticholiumperSeIII</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2014-04-28</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universit盲tsklinikum Heidelberg and its Commercial D </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A randomised, placebo-controlled, double-blind, monocentre study on the application of physostigminsalicylate (Anticholium庐) as adjunctive measure in perioperative sepsis/septic shock </td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> </td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.0</td> <td>10021881 - Infections and infestations</td> <td>10040047</td> <td>Sepsis</td> <td>PT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2012-001650-26/DE">DE</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2012-000447-27" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2012-000447-27 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> USKH_VL1</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2012-07-25</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Universit盲tsklinikum Schleswig-Holstein, Campus Kiel </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Pharmacokinetic trial in patients, with a good general condition before standard abdominal surgery</td> </tr> <tr> <td colspan="3"> <span class="label">Disease:</span> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2012-000447-27/DE">DE</a> <span class="status">(Temporarily Halted)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2012-000449-11" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2012-000449-11 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> EP250567</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2012-03-01</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Eero Pesonen </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Heparin dose (300 IU/kg vs. 600 IU/kg) in coroanry artery bypass grafting</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Patients undergoing elective coronary artery bypass grafting</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>21.1</td> <td>100000004865</td> <td>10068176</td> <td>Coronary artery bypass graft</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2012-000449-11/FI">FI</a> <span class="status">(Ongoing)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <i>(No results available)</i> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2011-005066-38" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2011-005066-38 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> CINC424AGB02</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2012-03-09</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Novartis Pharmaceuticals UK Ltd </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A UK open-label, multicentre, exploratory Phase II study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelof...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (PPV MF) or Post essential thrombocythemia myelofibrosis (PET-MF)</td> </tr> <tr> <td colspan="3"> <span class="label">Disease:</span> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2011-005066-38/GB">GB</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2011-005066-38/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2011-005082-21" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2011-005082-21 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> Uni-Koeln-1491</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2012-09-25</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>University of Cologne </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> Targeted BEACOPP variants in patients with newly diagnosed advanced classical Hodgkin Lymphoma</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> newly diagnosed advanced classical Hodgkin Lymphoma</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>20.0</td> <td> 100000004851</td> <td>10025319</td> <td>Lymphomas Hodgkin's disease</td> <td>HLGT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2011-005082-21/DE">DE</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2011-005082-21/results">View results</a> </td> </tr> </table> <table class="result"> <tr> <td style="width: 33%"> <input type="checkbox" name="enchx" value="2012-004439-22" title="Mark this result for download" style="display:none"/> <span class="label">EudraCT Number:</span> 2012-004439-22 </td> <td style="width: 33%"><span class="label">Sponsor Protocol Number:</span> CAIN457F2312</td> <td style="width: 33%"><span class="label">Start Date<span class="info-tip startdatetip">*</span>:</span> 2013-04-08</td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Sponsor Name:</span>Novartis Pharma Services AG </td> </tr> <tr> <td colspan="3"><span class="label">Full Title:</span> A Phase III randomized, double-blind, placebo-controlled multicenter study of subcutaneous secukinumab in prefilled syringes to demonstrate the efficacy at 24 weeks and to assess the long term effi...</td> </tr> <tr class="even"> <td colspan="3"><span class="label">Medical condition:</span> Psoriatic arthritis</td> </tr> <tr> <td colspan="3"> <table class="meddra" > <tr> <td style="width: 25%" class="label" rowspan="2"> Disease: </td> <td class="label">Version</td> <td class="label">SOC Term</td> <td class="label">Classification Code</td> <td class="label">Term</td> <td class="label">Level</td> </tr> <tr> <td>19.1</td> <td>100000004859</td> <td>10037160</td> <td>Psoriatic arthritis</td> <td>LLT</td> </tr> </table> </td> </tr> <tr class="even"> <td colspan="2"><span class="label">Population Age:</span> Adults, Elderly</td> <td><span class="label">Gender:</span> Male, Female</td> </tr> <tr> <td colspan="3"><span class="label">Trial protocol:</span> <a href="/ctr-search/trial/2012-004439-22/GB">GB</a> <span class="status">(Completed)</span> <a href="/ctr-search/trial/2012-004439-22/BE">BE</a> <span class="status">(Completed)</span> <a href="/ctr-search/trial/2012-004439-22/CZ">CZ</a> <span class="status">(Completed)</span> <a href="/ctr-search/trial/2012-004439-22/DE">DE</a> <span class="status">(Completed)</span> <a href="/ctr-search/trial/2012-004439-22/PL">PL</a> <span class="status">(Completed)</span> </td> </tr> <tr class="even"> <td colspan="3"> <span class="label">Trial results:</span> <a href="/ctr-search/trial/2012-004439-22/results">View results</a> </td> </tr> </table> </div> <div class="grid_3 columnContainer"> <div id="actualRss" class="search"> <strong>Subscribe to this Search</strong><br/> To subscribe to the RSS feed for this search click <a id="feed" href="javascript:void(0)" class="feed" style="margin-right:-0.3em"> here <img src="img/rss.png" style="vertical-align: -3px;" alt=""/> </a>. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days. </div> <table id="download-options" class="download"> <tr> <th style="padding: 8px 0 0;"><strong>Download Options:</strong></th> </tr> <tr> <th>Number of Trials to download:</th> </tr> <tr> <td class="download-number"> <select id="number" size="1" class="marginB12 w220px"> <option value="current_page">Trials shown on current page</option> <option value="selected">Selected Trials only</option> </select> <!-- <label for="current-radio">Trials shown on current page</label> <input id="current-radio" type="radio" name="number" value="current_page" checked> <br/> <label for="selected-radio">Selected Trials only</label> <input id="selected-radio" type="radio" name="number" value="selected" >--> </td> </tr> <tr> <th style="padding: 10px 0 0;">Download Content:</th> </tr> <tr> <td class="download-content"> <select id="dContent" size="1" class="marginB12 w220px"> <option value="summary">Summary Details</option> <option value="full">Full Trial Details</option> </select> <!-- <label for="summary-radio">Summary Details</label> <input id="summary-radio" type="radio" name="content" value="summary" checked> <br/> <label for="full-radio">Full Trial Details</label> <input id="full-radio" type="radio" name="content" value="full" > --> </td> </tr> <tr> <th style="padding: 10px 0 0;">Download Format:</th> </tr> <tr> <td class="download-format"> <select name="format" size="1" class="marginB12 w220px"> <option value="text">Plain Text</option> </select> </td> </tr> <tr> <td colspan="2" style="text-align:right;"> <input type="button" id="submit-download" class="padding04 marginB12" value="Download" /> </td> </tr> <tr> <td colspan="2"> <span class="downloadNote">Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.</span> </td> </tr> </table> </div> <div id="startdatetip-content" class="grid_12" style="display: none;"> <span>&bull; EEA CTAs: Date study was authorised to proceed</span><br/> <span>&bull; Outside EU/EEA: Date study was submitted in EudraCT</span><br/> </div> <div class="pager grid_8plus" class="margin-bottom: 6px;"> <strong>1</strong>&nbsp; <a href="&page=2">2</a>&nbsp; <a href="&page=3">3</a>&nbsp; <a href="&page=4">4</a>&nbsp; <a href="&page=5">5</a>&nbsp; <a href="&page=6">6</a>&nbsp; <a href="&page=7">7</a>&nbsp; <a href="&page=8">8</a>&nbsp; <a href="&page=9">9</a>&nbsp; <a href="&page=2" accesskey="n"> Next&#187; </a> <a href="&page=2212"> Last&#187;&#187; </a> </div> </div> <div id="tabs-2" style="display:inline-block" class="grid12"> <div class="nooutcome"> <img src="img/info.png" alt=""/> <strong>Query did not match any studies.</strong> </div> </div> </div> </div> <div class="container_12"> <span> For support, <a href="https://eudract.ema.europa.eu/contact.html" class="whitefooterlink" title="Click to open contact home page"> Contact us. </a> </span> </div> <div id="footerContainer" class="width100"> <div class="container_12" id="footerMenuContainer"> <span class="leftFooter"> The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. <span class="rightFooter"> <a href="/disclaimer.html" class="whitefooterlink controls"> Legal notice </a> </span> <br/> As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through <a href="https://euclinicaltrials.eu/" class="whitefooterlink" title="Click to open CTIS home page"> CTIS </a> . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website. <br/> <br/> European Medicines Agency &#169; 1995-Wed Nov 27 07:27:24 CET 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands </span> </div> </div> <div id="finalContainer" class="width100"> <div class="container_12"> <span class="leftFooter"><a href="http://www.ema.europa.eu" target="_blank"><img src="/ctr-search/img/ema_logo.png" width="300" height="48" alt="EMA"></a></span> <span class="rightFooter"><a href="http://www.hma.eu" target="_blank"><img src="/ctr-search/img/hma_logo.png" width="80" height="48" alt="HMA"></a></span> </div> </div> </body> </html> <script id="f5_cspm">(function(){var f5_cspm={f5_p:'NMKOAABLFELCMFFFIINBMOOEDOKIJBPAJLHEKBPADGFAJBBKHNCHKEOIAFGIMBCBJLCBMIJLAAIKLEPBIPGANBMPAANFCLFOPKIIFOPGNIGHKIMMHDKMDFDFIIOFJACF',setCharAt:function(str,index,chr){if(index>str.length-1)return str;return str.substr(0,index)+chr+str.substr(index+1);},get_byte:function(str,i){var s=(i/16)|0;i=(i&15);s=s*32;return((str.charCodeAt(i+16+s)-65)<<4)|(str.charCodeAt(i+s)-65);},set_byte:function(str,i,b){var s=(i/16)|0;i=(i&15);s=s*32;str=f5_cspm.setCharAt(str,(i+16+s),String.fromCharCode((b>>4)+65));str=f5_cspm.setCharAt(str,(i+s),String.fromCharCode((b&15)+65));return str;},set_latency:function(str,latency){latency=latency&0xffff;str=f5_cspm.set_byte(str,40,(latency>>8));str=f5_cspm.set_byte(str,41,(latency&0xff));str=f5_cspm.set_byte(str,35,2);return str;},wait_perf_data:function(){try{var wp=window.performance.timing;if(wp.loadEventEnd>0){var res=wp.loadEventEnd-wp.navigationStart;if(res<60001){var cookie_val=f5_cspm.set_latency(f5_cspm.f5_p,res);window.document.cookie='f5avr1377058531aaaaaaaaaaaaaaaa_cspm_='+encodeURIComponent(cookie_val)+';path=/;'+'';} return;}} catch(err){return;} setTimeout(f5_cspm.wait_perf_data,100);return;},go:function(){var chunk=window.document.cookie.split(/\s*;\s*/);for(var i=0;i<chunk.length;++i){var pair=chunk[i].split(/\s*=\s*/);if(pair[0]=='f5_cspm'&&pair[1]=='1234') {var d=new Date();d.setTime(d.getTime()-1000);window.document.cookie='f5_cspm=;expires='+d.toUTCString()+';path=/;'+';';setTimeout(f5_cspm.wait_perf_data,100);}}}} f5_cspm.go();}());</script>

Pages: 1 2 3 4 5 6 7 8 9 10